Low Doses Amitriptyline & Chronic Neck Pain
CompletedPhase 4NCT01561209
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this prospective randomized and controlled study is to evaluate the efficacy and safety of low dose of amitriptyline (5 mg) in the management of chronic neck pain.
Study details
- Official title
- Prospective Randomized & Controlled Study of the Role of Low Doses Amitriptyline in the Management of Chronic Neck Pain
- Conditions
- Interventions
- Drug: Amitryptiline
- Drug: Placebo
- Sponsor
- St Joseph University, Beirut, Lebanon
- Start date
- 2012-03
- Primary completion
- 2014-06
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Lebanon
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic neck pain (since more than 3 months, and more than 15 days/month) * Normal neurologic exam * X-ray = normal or loss of lordosis Exclusion Criteria: * Neurologic signs or symptoms * Past history of neck surgery * MRI = abnormal findings except for loss of lordosis * Past cervical trauma * severe depression * drug abuse * pregnancy * Follow-up not possible * cardiac rhythms problems * Glaucoma * Urinary tract obstruction or prostatism
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01561209